Hineline Lawrence J.

CIK 00015856971 companyNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001585697

Recent Transactions

50 trades

Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-11$66.47/sh−4,475→ 64 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-11$67.12/sh−64→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-11$66.54/sh−1,100→ 29 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-11$67.32/sh−29→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-11$65.28/sh−4,453→ 1,129 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-03-10−5,582→ 5,582 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-10$56.73/sh+4,539→ 4,539 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to purchase)
2024-03-10−4,539→ 4,539 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-10+5,582→ 5,582 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-07$66.26/sh−6,514→ 6,618 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-07$66.93/sh−6,618→ 0 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-06+13,132→ 13,132 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-03-06−13,132→ 26,266 total
Award
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-03-01+26,227→ 26,227 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-26$69.38/sh−6,867→ 288 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2024-02-26−5,882→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-26$69.81/sh−600→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-26$68.33/sh−300→ 7,155 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-26$70.15/sh−288→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-26$69.47/sh−5,282→ 600 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-26$36.89/sh+5,882→ 5,882 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-23+7,455→ 7,455 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-02-23−7,455→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-02$67.35/sh−185→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-02$66.61/sh−10,998→ 185 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-01+11,183→ 11,183 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2023-06-14$53.63/sh+40,472→ 40,472 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to purchase)
2023-06-14−11,762→ 5,882 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to purchase)
2023-06-14−40,472→ 0 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to purchase)
2023-06-14−25,082→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-06-14$64.37/sh−44,035→ 3,592 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-06-14$63.35/sh−34,227→ 47,627 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2023-06-14$56.73/sh+4,538→ 81,854 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-06-14$65.01/sh−3,592→ 0 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2023-06-14$23.94/sh+25,082→ 65,554 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2023-06-14$36.89/sh+11,762→ 77,316 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to purchase)
2023-06-14−4,538→ 9,078 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-03-13$44.97/sh−5,324→ 258 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-03-13$44.14/sh−258→ 0 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2023-03-10−5,582→ 11,164 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-03-10$42.52/sh−2,700→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-03-10$43.17/sh−12,963→ 2,700 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2023-03-10+5,582→ 5,582 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2023-03-09+15,663→ 15,663 total
Award
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2023-03-06+39,398→ 39,398 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-02-24$47.03/sh−7,455→ 0 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2023-02-23−7,455→ 7,455 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2023-02-23+7,455→ 7,455 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-02-21$48.72/sh−900→ 94 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2023-02-21$49.60/sh−94→ 0 total

Companies

Intra-Cellular Therapies, Inc.
VP of Finance, CFO & Secretary

Recent Filings

Address

C/O INTRA-CELLULAR THERAPIES, INC. 3960 BROADWAY

NEW YORK, NY, 10032

View on SEC.gov